Mochida Pharmaceutical Co., Ltd.
Mochida Pharmaceutical Co., Ltd. scores highest on Price (77) and lowest on Nitro (53). Its PosiPenta is 61.75 out of 100, better than most similar companies.
On the Penta Grid this week, Mochida Pharmaceutical Co., Ltd. is Grid #14 of 128 in the Healthcare sector in Japan, and Grid #266 of 1,818 in Japan.
Compared with similar companies in the Healthcare sector in Japan.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Mochida Pharmaceutical Co., Ltd. | 61.75 | 77 | 54 | 53 | 55 | 70 |
| JINS HOLDINGS Inc. | 50.83 | 28 | 57 | 34 | 74 | 61 |
| Kaken Pharmaceutical Co., Ltd. | 51.02 | 37 | 53 | 50 | 56 | 59 |
| Zeria Pharmaceutical Co., Ltd. | 56.59 | 86 | 62 | 37 | 40 | 57 |
| Mani, Inc. | 52.34 | 28 | 49 | 50 | 79 | 56 |
| Qol Holdings Co., Ltd. | 65.68 | 72 | 73 | 77 | 57 | 51 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 12.46 |
| P/B ratio | 0.80 |
EEarnings
| Trailing EPS | ₹155.32 |
| Forward EPS | ₹112.84 |
NNitro
| Price | 1935.00 |
| 52-week high | 2390.12 |
| 52-week low | 1765.61 |
| Fall from 52-week high | 19.0% |
TTorque
| Return on equity (ROE) | 6.77% |
| Debt-to-equity | 0.07 |
AAnchor
| Beta (price swings) | 0.08 |
| Market cap | ₹6,796 Cr |
| Insider holding | 36.33% |
| Dividend yield | 2.62% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Mochida Pharmaceutical Co., Ltd.'s PosiPenta score?
Mochida Pharmaceutical Co., Ltd.'s PosiPenta is 61.75 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does Mochida Pharmaceutical Co., Ltd. stand on the Penta Grid?
On the Penta Grid this week, Mochida Pharmaceutical Co., Ltd. is Grid #14 of 128 in the Healthcare sector in Japan, and Grid #266 of 1,818 in Japan.
Which PosiPenta pillar is strongest for Mochida Pharmaceutical Co., Ltd.?
Price (valuation), with a score of 77 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Mochida Pharmaceutical Co., Ltd.?
Nitro (momentum), with a score of 53 out of 100: around the middle of similar companies.
PositoAI is for research and education only and is not investment advice.